Physician profile
Angela M Pugsley
NPI 1548672413
$3,979.15
in general payments reported to CMS, 2019-2025
11 companies · $2,049 in 2025
The $2,049 reported for 2025 was more than what 92% of Adult Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $186).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $40.04 · 2023: $298 · 2024: $1,592 · 2025: $2,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,929 · Travel and Lodging: $1,751 · Education: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,928.52 |
| Travel and Lodging | $1,750.62 |
| Education | $259.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,553.79 | 2023-2025 | Inspire |
| Harmony Biosciences LLC | $567.74 | 2023-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $302.50 | 2022-2025 | |
| Axsome Therapeutics, INC. | $220.46 | 2023-2025 | Sunosi |
| Novo Nordisk INC | $92.73 | 2023 | Wegovy |
| Idorsia Pharmaceuticals US INC | $81.71 | 2024 | Quviviq |
| Resmed Corp | $58.92 | 2024-2025 | |
| Fisher & Paykel Healthcare INC | $43.62 | 2025 | Fisher & Paykel Healthcare |
| Zoll Respicardia, INC. | $21.68 | 2023 | Remede System |
| Philips North America LLC | $20.01 | 2022 | |
| Lilly USA, LLC | $15.99 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Pugsley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.